Reviewing of term sheet for licensing technology for Aptimmune Biologics

Collyer Law advised Aptimmune Biologics, Inc, a US based company which specializes in developing revolutionary mucosal vaccines, made with Barricade (TM) Formulation Technology, in connection with reviewing of term sheet for licensing technology.

Tags:

LifeSciences & Healthtech
Technology

Deals & Matters

Featured Posts

Azmul Haque named in Asia Super 50 TMT Lawyers 2022

Advising Sky Mavis on US$150 M Series B fundraising

Collyer Law named in India Business Law Journal as a Top International Law Firm for India work.

Collyer Law advises Holmusk on acquisition of digital heath solution business

Collyer Law is a finalist at the 2021 IDEX Legal Awards

Azmul Haque featured in Asian Legal Business "Singapore: A fertile ground for LegalTech innovation"

Advising Green Packet Berhad on acquisition of Xendity

The International A-List 2020: Top 100 India-focused lawyers

Collyer Law wins "India Practice - Asian Law Firm of the Year" at the ALB India Law Awards

The A-List 2019: Singapore's Top 100 Lawyers

Recent Posts

Azmul Haque named in Asia Super 50 TMT Lawyers 2022

Advising a High-Net-Worth Individual on company law

Collyer Law is a finalist in the ALB India Law Awards 2022

Collyer Law named a finalist in the ALB SE Asia Law Awards 2022

Azmul Haque at Fireside Chat for SAL-INSEAD Legal Leadership Program

Advising San Francisco-based venture fund on share transfers

Advising a senior executive on company and employment law

Advising a former senior executive at Cisco on employment matters

Advising a Singapore-based venture capital firm on company law

Advising a global technology firm on company law agreements

Reviewing of term sheet for licensing technology for Aptimmune Biologics

Featured Posts

Recent Posts

Archive

Search By Tags

Follow Us